Progressive subretinal fibrosis and uveitis syndrome: clinical course and multimodal imaging analysis in a late-onset case.
4 affiliations
- 1Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. [email protected].
- 2Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele-Milan, Italy. [email protected].
- 3Doheny Eye Institute, Los Angeles, CA, USA.
- 4Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Abstract
Purpose
To describe the longitudinal clinical and multimodal imaging findings of a patient with progressive subretinal fibrosis and uveitis (SFU) syndrome.Case presentation
Case report. An 85-year-old woman with a history of cardiomyopathy, systemic hypertension, hyperlipidemia and hypothyroidism presented with a 5-day history of acute bilateral visual decline. At baseline, best-corrected Snellen visual acuity was 20/80 OD and 20/400 OS. Fundus examination revealed multifocal chorioretinal lesions with fibrotic subretinal changes and vitreous inflammation. Fundus autofluorescence demonstrated scattered areas of hypoautofluorescence with hyperautofluorescent borders, and fluorescein angiography revealed window defects with late staining but no leakage. Spectral-domain optical coherence tomography (SD-OCT) showed diffuse retinal pigment epithelium (RPE)-Bruch's membrane (BrM) splitting and overlying fuzzy subretinal hyperreflective material (SHRM). Primary vitreoretinal lymphoma and multifocal choroiditis were initially suspected; however, systemic and uveitis work-up was negative. The patient's advanced age was atypical for new-onset SFU and further contributed to diagnostic uncertainty. Despite oral corticosteroid treatment and intravitreal dexamethasone implants OU, the disease progressed relentlessly, leading to widespread subretinal fibrosis and chorioretinal atrophy, and severe visual decline (20/100 OD, counting fingers OS at 12 months).Conclusion
SFU is a rare, aggressive, and underrecognized immune-mediated uveitic syndrome that can masquerade as neoplastic or inflammatory chorioretinopathies. This atypical late-onset case expands the known age spectrum of the disease and highlights the importance of considering SFU in rapidly progressive chorioretinal fibrosis in older adults. OCT biomarkers - particularly RPE-BrM splitting and fuzzy SHRM - may signal early SFU, emphasizing timely recognition and immunomodulatory therapy to prevent vision loss.
Related
- Presumed non-inflammatory bilateral peripapillary subretinal fibrosis in adolescent patients.
- DTCAMD, a disease-associated truncated form of CRYAB in neovascular age-related macular degeneration: a potential driver of subretinal fibrosis
- Automated quantitative analysis can support the identification of progressive pulmonary fibrosis in fibrotic interstitial lung disease.
- Differentiating nonfluent/agrammatic and logopenic primary progressive aphasia in Catalan-Spanish bilinguals by applying multilingual multimodal machine learning to connected speech
- Clinical characteristics, risk factors, and prognosis of intrapapillary hemorrhage and peripapillary subretinal hemorrhage: a systematic review
BibTeX
@article{feo2026progressive,
title = {{Progressive subretinal fibrosis and uveitis syndrome: clinical course and multimodal imaging analysis in a late-onset case.}},
author = {Alessandro Feo and Phillip P Le and Kirk Hou and Colin A McCannel and Edmund Tsui and Judy L Chen},
journal = {Journal of ophthalmic inflammation and infection},
year = {2026},
month = aug,
doi = {10.1186/s12348-026-00626-6},
url = {https://europepmc.org/article/MED/42957930},
note = {CC BY},
}
RIS
TY - JOUR
TI - Progressive subretinal fibrosis and uveitis syndrome: clinical course and multimodal imaging analysis in a late-onset case.
AU - Alessandro Feo
AU - Phillip P Le
AU - Kirk Hou
AU - Colin A McCannel
AU - Edmund Tsui
AU - Judy L Chen
PY - 2026
DA - 2026/08/03
JO - Journal of ophthalmic inflammation and infection
DO - 10.1186/s12348-026-00626-6
UR - https://europepmc.org/article/MED/42957930
AB - Purpose To describe the longitudinal clinical and multimodal imaging findings of a patient with progressive subretinal fibrosis and uveitis (SFU) syndrome.Case presentation Case report. An 85-year-old woman with a history of cardiomyopathy, systemic hypertension, hyperlipidemia and hypothyroidism presented with a 5-day history of acute bilateral visual decline. At baseline, best-corrected Snellen visual acuity was 20/80 OD and 20/400 OS. Fundus examination revealed multifocal chorioretinal lesions with fibrotic subretinal changes and vitreous inflammation. Fundus autofluorescence demonstrated scattered areas of hypoautofluorescence with hyperautofluorescent borders, and fluorescein angiography revealed window defects with late staining but no leakage. Spectral-domain optical coherence tomography (SD-OCT) showed diffuse retinal pigment epithelium (RPE)-Bruch's membrane (BrM) splitting and overlying fuzzy subretinal hyperreflective material (SHRM). Primary vitreoretinal lymphoma and multifocal choroiditis were initially suspected; however, systemic and uveitis work-up was negative. The patient's advanced age was atypical for new-onset SFU and further contributed to diagnostic uncertainty. Despite oral corticosteroid treatment and intravitreal dexamethasone implants OU, the disease progressed relentlessly, leading to widespread subretinal fibrosis and chorioretinal atrophy, and severe visual decline (20/100 OD, counting fingers OS at 12 months).Conclusion SFU is a rare, aggressive, and underrecognized immune-mediated uveitic syndrome that can masquerade as neoplastic or inflammatory chorioretinopathies. This atypical late-onset case expands the known age spectrum of the disease and highlights the importance of considering SFU in rapidly progressive chorioretinal fibrosis in older adults. OCT biomarkers - particularly RPE-BrM splitting and fuzzy SHRM - may signal early SFU, emphasizing timely recognition and immunomodulatory therapy to prevent vision loss.
SN - 1869-5760
ER -